Androgen Deprivation Therapy: Minimizing Exposure and Mitigating Side Effects

Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer

2006 • 1,411 citations

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

2007 • 1,198 citations

Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

2009 • 1,070 citations

Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

1972 • 1,030 citations

Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy

2006 • 956 citations

Duration of Androgen Suppression in the Treatment of Prostate Cancer

2009 • 927 citations

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

2005 • 903 citations

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study

2010 • 901 citations

Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer

2008 • 669 citations

Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer

2011 • 665 citations

Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer

2003 • 656 citations

Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610

2008 • 634 citations

Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline

2007 • 550 citations

Randomized Controlled Trial of Resistance or Aerobic Exercise in Men Receiving Radiation Therapy for Prostate Cancer

2008 • 523 citations

Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality

2007 • 516 citations

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

2007 • 508 citations

Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial

2005 • 375 citations

National Practice Patterns and Time Trends in Androgen Ablation for Localized Prostate Cancer

2003 • 342 citations

Randomized Controlled Trial of Annual Zoledronic Acid to Prevent Gonadotropin-Releasing Hormone Agonist–Induced Bone Loss in Men With Prostate Cancer

2007 • 325 citations

Survival Following Primary Androgen Deprivation Therapy Among Men With Localized Prostate Cancer

2008 • 317 citations

Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma.

1990 • 314 citations

Side effects of androgen deprivation therapy: monitoring and minimizing toxicity

2003 • 240 citations

Altered cognitive function in men treated for prostate cancer with luteinizing hormone‐releasing hormone analogues and cyproterone acetate: a randomized controlled trial

2002 • 231 citations

Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model

1996 • 192 citations

Influence of Local Tumor Control on Distant Metastases and Cancer Related Mortality After External Beam Radiotherapy for Prostate Cancer

2008 • 181 citations

Natural History of Progression After PSA Elevation Following Radical Prostatectomy

1999 • 156 citations

Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: A pilot study

1996 • 147 citations

The Effects of Combined Androgen Blockade on Cognitive Function During the First Cycle of Intermittent Androgen Suppression in Patients With Prostate Cancer

2003 • 144 citations

A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy

2011 • 124 citations

Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT

2010 • 117 citations

Impact of Androgen-Deprivation Therapy on Cognitive Function in Men With Nonmetastatic Prostate Cancer

2010 • 111 citations

Bone mineral density in patients with prostate cancer without bone metastases treated with intermittent androgen suppression

2004 • 94 citations

Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy

2005 • 91 citations

Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime

2005 • 74 citations

Outcomes for patients with high‐grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy

2009 • 62 citations

Long‐term effects of intermittent androgen suppression on testosterone recovery and bone mineral density: results of a 33‐month observational study

2009 • 57 citations

Intermittent Androgen Suppression in the Treatment of Metastatic Prostate Cancer

2000 • 56 citations

Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate: A Randomized Controlled Trial

2006 • 56 citations

Does Hormone Therapy Reduce Disease Recurrence in Prostate Cancer Patients Receiving Dose-Escalated Radiation Therapy? An Analysis of Radiation Therapy Oncology Group 94-06

2011 • 50 citations

Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up.

1999 • 48 citations

Promoting general health during androgen deprivation therapy (ADT): A rapid 10-step review for your patients

2005 • 47 citations

Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control

2006 • 45 citations

6-Month Androgen Suppression Plus Radiation Therapy vs Radiation Therapy Alone for Patients With Clinically Localized Prostate Cancer: A Randomized Controlled Trial

2005 • 41 citations

Impact of Hormonal Therapy on Intermediate Risk Prostate Cancer Treated With Combination Brachytherapy and External Beam Irradiation

2009 • 36 citations

Predictors of mortality after prostate-specific antigen failure

2006 • 36 citations

Intermediate End Point for Prostate Cancer-Specific Mortality Following Salvage Hormonal Therapy for Prostate-Specific Antigen Failure

2004 • 35 citations

Educational Tool-kit on Diet and Exercise: Survey of Prostate Cancer Patients About to Receive Androgen Deprivation Therapy

2010 • 26 citations

Quality of life and satisfaction with outcome among prostate-cancer survivors

2008 • 25 citations

Effect of Once-Weekly Oral Alendronate on Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Randomized Trial

2008 • 22 citations

Mature Results of the Ottawa Phase II Study of Intermittent Androgen-Suppression Therapy in Prostate Cancer: Clinical Predictors of Outcome

2007 • 21 citations

Intermittent Endocrine Therapy for Advanced Prostate Cancer

1987 • 9 citations

A Phase III Randomized Trial of Intermittent vs. Continuous Androgen Suppression for PSA Progression after Radical Therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013)

2011 • 3 citations